CDC Logo Tuberculosis Information CD-ROM   Image of people
jump over main navigation bar to content area
TB Guidelines
Surveillance Reports
Slide Sets
TB-Related MMWRs and Reports
Education/Training Materials
Ordering Information


U.S. Department of Health and Human Services


MMWRs - 2000

Drug-Susceptible Tuberculosis Outbreak in a State Correctional Facility Housing HIV-Infected Inmates --- South Carolina, 1999--2000 - MMWR 2000; 49 (No. 46)
Recall of Isoniazid Used for Susceptibility Testing for Tuberculosis -- MMWR 2000; 49 (No. 34)
Missed Opportunities for Prevention of Tuberculosis Among Persons With HIV Infection - MMWR 2000; 49 (No. 30)
Update: Nucleic Acid Amplification Tests for Tuberculosis -- MMWR 2000; 49 (No. 26)
Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection - MMWR 2000; 49 (No. RR-6)
Misdiagnoses of Tuberculosis Resulting From Laboratory Cross-Contamination of Mycobacterium Tuberculosis Cultures --- New Jersey, 1998. - MMWR 2000; 49 (No. 19)
HIV - Related Tuberculosis in a Transgender Network---Baltimore, Maryland, and New York City Area - MMWR 2000; 49 (No. 15)
Updated Guidelines for the Use of Rifabutin or Rifampin for the Treatment and Prevention of Tuberculosis Among HIV-Infected Patients Taking Protease Inhibitors or Nonnucleoside Reverse Transcriptase Inhibitors - MMWR 2000; 49 (No. 9)


Released October 2008
Centers for Disease Control and Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination -

Please send comments/suggestions/requests to:, or to
CDC/Division of Tuberculosis Elimination
Communications, Education, and Behavioral Studies Branch
1600 Clifton Rd., NE - Mailstop E-10, Atlanta, GA 30333